Literature DB >> 16191453

Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs).

Sarah E Blutt1, Kelly L Warfield, Christine M O'Neal, Mary K Estes, Margaret E Conner.   

Abstract

Critical factors that are important in protection from rotavirus infection have remained elusive. We demonstrate here that inbred mice (C57BL/6 and BALB/c) exhibit differences in: (1) susceptibility to and (2) VLP-induced protection from rotavirus infection. Comparing protection induced by 2/4/6/7-VLPs with inactivated and live rotavirus, intranasally induced protection was dependent on dsRNA or minor structural proteins and correlated with intestinal antibody, while orally induced protection required immunization with replicating virus. Combination oral/intranasal vaccination did not improve VLP protective efficacy. These studies indicate that host, viral, and vaccine factors determine the level of protective efficacy induced by VLPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191453     DOI: 10.1016/j.vaccine.2005.08.090

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity.

Authors:  Sarah E Blutt; Kelly L Warfield; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

3.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Active viremia in rotavirus-infected mice.

Authors:  Sarah E Blutt; Martijn Fenaux; Kelly L Warfield; Harry B Greenberg; Margaret E Conner
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.

Authors:  Ioanna Skountzou; Fu-Shi Quan; Sailaja Gangadhara; Ling Ye; Andrei Vzorov; Periasamy Selvaraj; Joshy Jacob; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

6.  Lymphotoxin alpha-deficient mice clear persistent rotavirus infection after local generation of mucosal IgA.

Authors:  Uri Lopatin; Sarah E Blutt; Margaret E Conner; Brian L Kelsall
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.

Authors:  Robin Uchiyama; Benoit Chassaing; Benyue Zhang; Andrew T Gewirtz
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

8.  FoxP3+ regulatory T cells are not important for rotavirus clearance or the early antibody response to rotavirus.

Authors:  Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  Microbes Infect       Date:  2013-10-02       Impact factor: 2.700

9.  Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response.

Authors:  Emily M Deal; Maria C Jaimes; Sue E Crawford; Mary K Estes; Harry B Greenberg
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

10.  Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route.

Authors:  Aurélie Girard; Elodie Roques; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.